Jul 29, 2019 / 11:00AM GMT
Operator
Good day, ladies and gentlemen, and welcome to the Q1 FY '20 Earnings Conference Call of Alembic Pharmaceuticals Limited.
We have with us today from the management Mr. Pranav Amin, Managing Director; Mr. R.K. Baheti, Director, Finance and CFO; Mr. Mitanshu Shah, Head of Finance; Mr. Jesal Shah, Head Strategy; and Mr. Ajay Kumar Desai, Senior VP Finance. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. R.K. Baheti. Thank you, and over to you, sir.
Raj Kumar Shreeram Baheti - Alembic Pharmaceuticals Limited - Director of Finance, CFO & Executive Director
Thank you, and thank you all participants for joining the Q1 conference call. I will straightaway go to the numbers.
During the quarter, our total revenue grew by 10% to INR 949 crores. EBITDA at INR 233 crore is 25% of sales.
Pre R&D EBITDA is 38% of sales. Profit before exceptional items and tax went up by 58% to INR 192 crores while post exceptional item and tax, it went up by 37% to INR 124 croresâ¦
Q1 2020 Alembic Pharmaceuticals Ltd Earnings Call Transcript
Jul 29, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers